Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
15
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| FMR LLC | Other | 8 | $0 | $0 | 2017-11-07 |
| Hohneker John | Director | 2 | $0 | $0 | 2017-11-07 |
| Wadsworth Samuel C. | Chief Scientific Officer | 5 | $0 | $0 | 2017-11-07 |
| Crombez Eric | Chief Medical Officer | 6 | $0 | $0 | 2017-11-07 |
| Jenkins Annalisa | President and CEO | 9 | $0 | $0 | 2017-11-07 |
| Dybbs Michael | Director | 7 | $12.50M | $0 | 2017-11-07 |
| Morris Arlene | Director | 5 | $0 | $0 | 2017-11-07 |
| Thistle Mary | Chief Operating Officer | 7 | $0 | $0 | 2017-11-07 |
| Colowick Alan | Director | 5 | $0 | $0 | 2017-11-07 |
| GEMAYEL GEORGES | Director | 5 | $0 | $0 | 2017-11-07 |
| MIGAUSKY GEORGE V | Director | 5 | $0 | $0 | 2017-11-07 |
| Clark K. Reed | See Remarks | 5 | $0 | $50.0K | 2017-02-01 |
| Franchi Jean M. | Chief Financial Officer | 2 | $0 | $0 | 2017-02-01 |
| Gupta Rishi | Director, 10% Owner | 6 | $2.60M | $0 | 2016-05-19 |
| ISALY SAMUEL D | Director, 10% Owner | 5 | $2.60M | $0 | 2015-10-27 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Colowick Alan | Director | D To issuer deriv | 2017-11-07 | 2017-11-07 | 44,474 | — | $0 | 0 | SEC↗ |
| Colowick Alan | Director | D To issuer deriv | 2017-11-07 | 2017-11-07 | 32,069 | — | $0 | 0 | SEC↗ |
| Colowick Alan | Director | D To issuer deriv | 2017-11-07 | 2017-11-07 | 17,000 | — | $0 | 0 | SEC↗ |
| Crombez Eric | Chief Medical Officer | D To issuer deriv | 2017-11-07 | 2017-11-07 | 80,396 | — | $0 | 0 | SEC↗ |
| Crombez Eric | Chief Medical Officer | D To issuer deriv | 2017-11-07 | 2017-11-07 | 50,000 | — | $0 | 0 | SEC↗ |
| Crombez Eric | Chief Medical Officer | D To issuer deriv | 2017-11-07 | 2017-11-07 | 128,292 | — | $0 | 0 | SEC↗ |
| Crombez Eric | Chief Medical Officer | D To issuer deriv | 2017-11-07 | 2017-11-07 | 50,000 | — | $0 | 0 | SEC↗ |
| Dybbs Michael | Director | D To issuer deriv | 2017-11-07 | 2017-11-07 | 17,000 | — | $0 | 0 | SEC↗ |
| Dybbs Michael | Director | D To issuer deriv | 2017-11-07 | 2017-11-07 | 32,069 | — | $0 | 0 | SEC↗ |
| GEMAYEL GEORGES | Director | D To issuer deriv | 2017-11-07 | 2017-11-07 | 44,474 | — | $0 | 0 | SEC↗ |
| GEMAYEL GEORGES | Director | D To issuer deriv | 2017-11-07 | 2017-11-07 | 17,000 | — | $0 | 0 | SEC↗ |
| GEMAYEL GEORGES | Director | D To issuer deriv | 2017-11-07 | 2017-11-07 | 32,069 | — | $0 | 0 | SEC↗ |
| Hohneker John | Director | D To issuer deriv | 2017-11-07 | 2017-11-07 | 38,000 | — | $0 | 0 | SEC↗ |
| Jenkins Annalisa | President and CEO | D To issuer deriv | 2017-11-07 | 2017-11-07 | 192,000 | — | $0 | 0 | SEC↗ |
| Jenkins Annalisa | President and CEO | D To issuer deriv | 2017-11-07 | 2017-11-07 | 74,375 | — | $0 | 0 | SEC↗ |
| Jenkins Annalisa | President and CEO | D To issuer deriv | 2017-11-07 | 2017-11-07 | 342,113 | — | $0 | 0 | SEC↗ |
| Jenkins Annalisa | President and CEO | D To issuer deriv | 2017-11-07 | 2017-11-07 | 160,000 | — | $0 | 0 | SEC↗ |
| Jenkins Annalisa | President and CEO | D To issuer deriv | 2017-11-07 | 2017-11-07 | 150,000 | — | $0 | 0 | SEC↗ |
| Jenkins Annalisa | President and CEO | D To issuer deriv | 2017-11-07 | 2017-11-07 | 481,696 | — | $0 | 0 | SEC↗ |
| MIGAUSKY GEORGE V | Director | D To issuer deriv | 2017-11-07 | 2017-11-07 | 17,000 | — | $0 | 0 | SEC↗ |
| MIGAUSKY GEORGE V | Director | D To issuer deriv | 2017-11-07 | 2017-11-07 | 32,069 | — | $0 | 0 | SEC↗ |
| MIGAUSKY GEORGE V | Director | D To issuer deriv | 2017-11-07 | 2017-11-07 | 55,772 | — | $0 | 0 | SEC↗ |
| Morris Arlene | Director | D To issuer deriv | 2017-11-07 | 2017-11-07 | 32,069 | — | $0 | 0 | SEC↗ |
| Morris Arlene | Director | D To issuer deriv | 2017-11-07 | 2017-11-07 | 44,474 | — | $0 | 0 | SEC↗ |
| Morris Arlene | Director | D To issuer deriv | 2017-11-07 | 2017-11-07 | 17,000 | — | $0 | 0 | SEC↗ |
| Thistle Mary | Chief Operating Officer | D To issuer deriv | 2017-11-07 | 2017-11-07 | 60,000 | — | $0 | 0 | SEC↗ |
| Thistle Mary | Chief Operating Officer | D To issuer deriv | 2017-11-07 | 2017-11-07 | 27,711 | — | $0 | 0 | SEC↗ |
| Thistle Mary | Chief Operating Officer | D To issuer deriv | 2017-11-07 | 2017-11-07 | 65,000 | — | $0 | 0 | SEC↗ |
| Thistle Mary | Chief Operating Officer | D To issuer deriv | 2017-11-07 | 2017-11-07 | 17,104 | — | $0 | 0 | SEC↗ |
| Thistle Mary | Chief Operating Officer | D To issuer deriv | 2017-11-07 | 2017-11-07 | 180,815 | — | $0 | 0 | SEC↗ |
| Wadsworth Samuel C. | Chief Scientific Officer | D To issuer deriv | 2017-11-07 | 2017-11-07 | 60,000 | — | $0 | 0 | SEC↗ |
| Wadsworth Samuel C. | Chief Scientific Officer | D To issuer deriv | 2017-11-07 | 2017-11-07 | 50,000 | — | $0 | 0 | SEC↗ |
| Wadsworth Samuel C. | Chief Scientific Officer | D To issuer | 2017-11-07 | 2017-11-07 | 278,035 | — | $0 | 0 | SEC↗ |
| FMR LLC | Other | U Tender | 2017-11-07 | 2017-11-09 | 3,838,249 | $6.00 | $23.03M | 0 | SEC↗ |
| FMR LLC | Other | U Tender | 2017-11-07 | 2017-11-09 | 5,057 | $6.00 | $30.3K | 0 | SEC↗ |
| FMR LLC | Other | U Tender | 2017-11-07 | 2017-11-09 | 1,050,016 | $6.00 | $6.30M | 0 | SEC↗ |
| Jenkins Annalisa | President and CEO | A Award deriv | 2017-07-03 | 2017-07-05 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Morris Arlene | Director | A Award deriv | 2017-05-25 | 2017-05-26 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Colowick Alan | Director | A Award deriv | 2017-05-25 | 2017-05-26 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Dybbs Michael | Director | A Award deriv | 2017-05-25 | 2017-05-26 | 17,000 | — | $0 | 17,000 | SEC↗ |
| GEMAYEL GEORGES | Director | A Award deriv | 2017-05-25 | 2017-05-26 | 17,000 | — | $0 | 17,000 | SEC↗ |
| MIGAUSKY GEORGE V | Director | A Award deriv | 2017-05-25 | 2017-05-26 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Thistle Mary | Chief Operating Officer | A Award deriv | 2017-02-01 | 2017-02-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Franchi Jean M. | Chief Financial Officer | A Award deriv | 2017-02-01 | 2017-02-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Crombez Eric | Chief Medical Officer | A Award deriv | 2017-02-01 | 2017-02-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Clark K. Reed | SVP of Pharmaceutical Develo | A Award deriv | 2017-02-01 | 2017-02-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Wadsworth Samuel C. | Chief Scientific Officer | A Award deriv | 2017-02-01 | 2017-02-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Jenkins Annalisa | President and CEO | A Award deriv | 2017-02-01 | 2017-02-03 | 192,000 | — | $0 | 192,000 | SEC↗ |
| Hohneker John | Director | A Award deriv | 2017-01-18 | 2017-01-20 | 38,000 | — | $0 | 38,000 | SEC↗ |
| Clark K. Reed | SVP of Pharmaceutical Develo | M Exercise deriv | 2016-06-07 | 2016-06-08 | 5,000 | — | $0 | 114,739 | SEC↗ |
| Clark K. Reed | SVP of Pharmaceutical Develo | M Exercise | 2016-06-07 | 2016-06-08 | 5,000 | $0.38 | $1.9K | 5,000 | SEC↗ |
| Clark K. Reed | SVP of Pharmaceutical Develo | S Sale | 2016-06-07 | 2016-06-08 | 5,000 | $10.00 | $50.0K | 0 | SEC↗ |
| Colowick Alan | Director | A Award deriv | 2016-05-19 | 2016-05-23 | 32,069 | — | $0 | 32,069 | SEC↗ |
| Dybbs Michael | Director | A Award deriv | 2016-05-19 | 2016-05-23 | 32,069 | — | $0 | 32,069 | SEC↗ |
| GEMAYEL GEORGES | Director | A Award deriv | 2016-05-19 | 2016-05-23 | 32,069 | — | $0 | 32,069 | SEC↗ |
| Gupta Rishi | Director | A Award deriv | 2016-05-19 | 2016-05-23 | 32,069 | — | $0 | 32,069 | SEC↗ |
| MIGAUSKY GEORGE V | Director | A Award deriv | 2016-05-19 | 2016-05-23 | 32,069 | — | $0 | 32,069 | SEC↗ |
| Morris Arlene | Director | A Award deriv | 2016-05-19 | 2016-05-23 | 32,069 | — | $0 | 32,069 | SEC↗ |
| FMR LLC | 10% Owner | J Other | 2016-05-02 | 2016-05-03 | 2,106,784 | — | $0 | 4,893,322 | SEC↗ |
| Franchi Jean M. | Chief Financial Officer | A Award deriv | 2016-02-01 | 2016-02-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Jenkins Annalisa | President & CEO | A Award deriv | 2016-02-01 | 2016-02-02 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Clark K. Reed | See Remarks | A Award deriv | 2016-02-01 | 2016-02-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Crombez Eric | Chief Medical Officer | A Award deriv | 2016-02-01 | 2016-02-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Thistle Mary | Chief Business Officer | A Award deriv | 2016-02-01 | 2016-02-02 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Wadsworth Samuel C. | Chief Scientific Officer | A Award deriv | 2016-02-01 | 2016-02-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| FMR LLC | 10% Owner | C Conversion deriv | 2015-10-27 | 2015-10-29 | 15,000,000 | — | $0 | 0 | SEC↗ |
| FMR LLC | 10% Owner | C Conversion deriv | 2015-10-27 | 2015-10-29 | 4,761,313 | — | $0 | 0 | SEC↗ |
| Dybbs Michael | Director | C Conversion deriv | 2015-10-27 | 2015-10-29 | 3,208,711 | — | $0 | 0 | SEC↗ |
| Gupta Rishi | Director, 10% Owner | C Conversion deriv | 2015-10-27 | 2015-10-29 | 5,692,874 | — | $0 | 0 | SEC↗ |
| Gupta Rishi | Director, 10% Owner | C Conversion deriv | 2015-10-27 | 2015-10-29 | 9,500,000 | — | $0 | 0 | SEC↗ |
| ISALY SAMUEL D | Director, 10% Owner | C Conversion deriv | 2015-10-27 | 2015-10-29 | 5,692,874 | — | $0 | 0 | SEC↗ |
| ISALY SAMUEL D | Director, 10% Owner | C Conversion deriv | 2015-10-27 | 2015-10-29 | 9,500,000 | — | $0 | 0 | SEC↗ |
| FMR LLC | 10% Owner | C Conversion | 2015-10-27 | 2015-10-29 | 1,628,914 | — | $0 | 7,000,106 | SEC↗ |
| FMR LLC | 10% Owner | C Conversion | 2015-10-27 | 2015-10-29 | 5,131,713 | — | $0 | 5,371,192 | SEC↗ |
| Dybbs Michael | Director | C Conversion | 2015-10-27 | 2015-10-29 | 1,097,745 | — | $0 | 1,097,745 | SEC↗ |
| Dybbs Michael | Director | P Buy | 2015-10-27 | 2015-10-29 | 961,538 | $13.00 | $12.50M | 2,059,283 | SEC↗ |
| Gupta Rishi | Director, 10% Owner | C Conversion | 2015-10-27 | 2015-10-29 | 1,947,613 | — | $0 | 5,197,698 | SEC↗ |
| Gupta Rishi | Director, 10% Owner | P Buy | 2015-10-27 | 2015-10-29 | 200,000 | $13.00 | $2.60M | 5,397,698 | SEC↗ |
| Gupta Rishi | Director, 10% Owner | C Conversion | 2015-10-27 | 2015-10-29 | 3,250,085 | — | $0 | 3,250,085 | SEC↗ |
| ISALY SAMUEL D | Director, 10% Owner | C Conversion | 2015-10-27 | 2015-10-29 | 3,250,085 | — | $0 | 3,250,085 | SEC↗ |
| ISALY SAMUEL D | Director, 10% Owner | P Buy | 2015-10-27 | 2015-10-29 | 200,000 | $13.00 | $2.60M | 5,397,698 | SEC↗ |
| ISALY SAMUEL D | Director, 10% Owner | C Conversion | 2015-10-27 | 2015-10-29 | 1,947,613 | — | $0 | 5,197,698 | SEC↗ |